BiondVax Pharmaceuticals Ltd. Gains 40.66%
Thu, Jan 21, 2021 at 05:30 PM
BiondVax Pharmaceuticals Ltd. (BVXV:NASDAQ) soared at $5.95, a gain of 40.7%. The stock appeared on our News Catalysts scanner on Tue 12 Jan 21 at 10:59 AM in the 'MISCELLANEOUS' category. From Wed 06 Jan 21, the stock recorded 66.67% Up Days and 50.00% Green Days
About BiondVax Pharmaceuticals Ltd. (BVXV:NASDAQ)
BiondVax Pharmaceuticals Ltd is a clinical stage biopharmaceutical company. The Company is engaged in developing, manufacturing and commercializing immunomodulation therapies for infectious diseases.
Top 10 Gainers:
- BBIG (BBIG:NASDAQ), 196.1%
- Qutoutiao Inc. (QTT:NASDAQ), 61.34%
- ADTX (ADTX:NASDAQ), 45.59%
- Ideal Power Inc. (IPWR:NASDAQ), 44.57%
- BiondVax Pharmaceuticals Ltd. (BVXV:NASDAQ), 40.66%
- Celsion Corporation (CLSN:NASDAQ), 36.47%
- Corbus Pharmaceuticals Holdings, Inc. (CRBP:NASDAQ), 35.63%
- AzurRx BioPharma, Inc. (AZRX:NASDAQ), 34.55%
- ReWalk Robotics Ltd. (RWLK:NASDAQ), 32%
- Castor Maritime Inc. (CTRM:NASDAQ), 30.77%